Roch

In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer
Endpoints
Thu, 09/6/18 - 11:42 am
Genentech
Roch
Tecentriq
Avastin
lung cancer
FDA
Genentech allies with a metagenomics upstart in New York on a discovery deal jam packed with biobucks
Endpoints
Wed, 05/9/18 - 09:27 pm
Genentech
Roch
New York
Lodo Therapeutics
microbial DNA
Amgen acquires Filgrastim franchise rights from Roche
Yahoo/Fly on the Wall
Tue, 10/22/13 - 11:28 am
Roch
filgrastim
Amgen
pegfilgrastim